GPC1 and cancer: Specifically, GPC1 was found to be overexpressed and a biomarker of certain cancers with demonstrated ability to distinguish between healthy controls and advanced cancer patients with 100% accuracy40, while Syndecan-3 has not been implicated in cancer yet38.